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Perineural Invasion in Squamous Cell Carcinoma of the Oral Cavity:
Histology, Tumor Stage, and Outcome
Roman D. Laske, MD;* Irene Scholz;* Kristian Ikenberg, MD; Christian Meerwein, MD;
Domenic G. Vital, MD; Gabriela Studer, MD; Matthias R€ossle, MD; Gerhard F. Huber, MD
Objectives/Hypothesis: To analyze the impact of different types of perineural invasion (PNI) in squamous cell carcinoma
(SCC) of the oral cavity on overall survival and recurrence rate, with a special focus on histologic subtypes and tumor stage.
Study Design: Retrospective case-control study with clinicopathological analysis.
Methods: Seventeen patients who received primary surgical treatment for SCC of the oral cavity with PNI were matched
to a control group. In a histologic review, PNI was classified into subtypes according to an adapted Liebig classification. The
term type A was used to describe tumor invasion into the nerve, whereas type B was used to describe circumferential growth
around the nerve. Clinical charts were reviewed, and a Kaplan-Meier survival analysis was performed.
Results: The recurrence-free survival rates were 47.1% versus 80.4% (PNI vs. matched control group, P< 0.05), 60.0%
versus 94.1% (PNI in stage I and II disease vs. matched control group, P< 0.05) and 41.7% versus 73.5% (PNI in stage III and
IV disease vs. matched control group, P<0.05). In most cases (n5 9) of PNI, both histologic subtypes (type A and type B) were
present. Five cases exclusively showed type A, and three cases exclusively showed type B.
Conclusions: Perineural invasion in early disease oral carcinoma has a particularly high impact on survival. Both histo-
logic subtypes showed a significantly worse recurrence-free survival rate when compared to the control group.
Key Words: Perineural invasion, head and neck, squamous cell carcinoma, oral, histology.
Level of Evidence: 3.
INTRODUCTION
Perineural invasion (PNI)1 describes a malignant
tumor’s affinity for neural tissue2–4 and is associated
with adverse outcome in many different types of cancer.
In head and neck cancer, it is predominately found in
adenoid cystic carcinoma5 but also in squamous cell car-
cinoma (SCC).6 Whereas in the first it is anticipated
with the diagnosis, and a high local recurrence rate has
to be expected, in the latter it is assumed to be an addi-
tional independent risk factor.7 This is crucial in the
case of early disease, for example, tumor-node-metasta-
sis (TNM) tumor stage I in oral cavity carcinoma, for
which the presence of PNI can alter the extent of treat-
ment by adding adjuvant radiotherapy after surgical
resection.8 Although in the clinical setting PNI is treated
as a homogenous entity, there are different histologic
patterns of tumor cells interacting with nerve tissue
that lead to the diagnosis of PNI. The sheer presence of
tumor cells adjacent to a nerve does not ultimately qual-
ify for PNI diagnosis. A widely accepted definition of
PNI was provided by Liebig et al.9 The authors
described two histologic patterns that alone or in combi-
nation define PNI. One pattern is observed when clus-
ters of tumor cells are located within the peripheral
nerve sheath and infiltration to the epineurium, peri-
neurium, and endoneurium can be distinguished. The
criterion for the second pattern is met when tumor cells
encircle at least 33% of the circumference of a nerve.
The location of the affected part of the nerve, whether
within the tumor or at a site outside the tumor margin,
does not contribute to their definition of PNI.
Miller et al.10 analyzed subcategories of PNI accord-
ing to the location of PNI in comparison with the tumor
margin and analyzed cohorts with noncutaneous head
and neck SCCs. They observed a trend for a longer
disease-free survival for patients with strictly intratu-
moral PNI when compared to patients with additional
peripheral and extratumoral PNI.
The aim of the current study was to use a classifica-
tion system based on the definitions by Liebig et al.9 to
analyze the recurrence-free survival of a homogenous
group of patients with SCC of the oral cavity. To our
knowledge, this is the first study analyzing the two dif-
ferent kinds of PNI patterns described by Liebig et. al in
a comparing clinical context.
MATERIALS AND METHODS
Patients with SCC of the oral cavity who underwent pri-
mary surgery at a single tertiary referral center for head and
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neck surgery between 2000 and 2008, and whose histopathology
reports mentioned PNI, were included. The time points were
chosen to allow a follow-up period of at least 5 years. Seventeen
patients were identified, and their histopathological slides were
reviewed by a pathology resident (I.S.) and a head and neck
pathologist (M.R.). In brief, histological slides of the cases were
retrieved from the archives of the Institute of Surgical Pathol-
ogy, University Hospital Zurich. Hematoxylin and eosin-stained
slides were reviewed for presence, number of affected nerves,
and pattern of PNI. In all cases, PNI was confirmed. The pat-
tern of PNI was assessed according to a modified Liebig classifi-
cation, as shown synoptically in Figure 1 and histologically in
Figure 2. The term type A was used to describe the pattern
when direct infiltration of tumor cells into a nerve was
observed. The term type B describes tumor cells encircling at
least 33% of a nerve.
The initial clinical presentation and the clinical course of
disease in the 5-year follow-up period were reviewed retrospec-
tively in the patient charts. Collected parameters included age
at primary surgery; gender; tumor localization within the oral
cavity; tumor stage with both TNM and general stage (I to IV) ;
and whether they received adjuvant radiotherapy or not. At our
Fig. 1. Histologic subcategories.
Fig. 2. Representative histological sections demonstrating perineural invasion (PNI) of squamous cell carcinoma: (a–c) Infiltration of the epi-
neurium and perineurium or (d–e) endoneurium representing type A according to the modified Liebig classification. (f) Involvement of at
least 33% of the perineural circumference represents classification as Liebig type B. Arrows5 carcinoma, N5 nerve. (a,d,f) hematoxylin
and eosin stains; (b) Elastica van Gieson stain; and (c1e) immunohistochemical pancytokeratin staining labeling carcinomatous infiltrates.
Scale bars: a–c 1 mm, d–e 500 mm, f 100 mm.
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institution, the decision on adjuvant radiotherapy with or with-
out concomitant chemotherapy is made at an interdisciplinary
tumor board based on the patient’s individual medical history.
Generally, PNI, lymphangiosis, N1 stage, and a T stage of 3 or
higher lead to recommending the patient adjuvant radiotherapy.
Accordingly, concomitant chemotherapy is added for patients
with adequate renal function and age below 70 years.
Data were compared to a matched control group of
patients who also underwent primary surgery for oral SCC, but
with no PNI mentioned in the histopathology report. Each PNI
patient was matched with three no PNI patients, resulting in
51 patients in the no PNI control group. Matching was
performed according to age at primary therapy, gender, and
tumor stage (I to IV). Figure 3 gives a schematic overview of
the study setup.
Kaplan-Meier survival analysis (IBM SPSS Statistics for
Windows, Version 22.0; IBM Corp., Armonk, NY) was used to
calculate recurrence-free survival and overall survival rates and
the log-rank test to identify significant differences.
The study was performed according to the rules of ethics
committee of the local authority.
RESULTS
Demographic and clinical data is shown in Table I
and Table II. The male-to-female ratio was 10:7 and the
average age was 566 9 years (range 39–72). At time of
primary surgery, five patients of the study group suf-
fered from early disease (TNM stage I and II) and 12
patients had already regionally advanced disease (TNM
stage III and IV). Within the oral cavity, the primary
site of cancer was the floor of mouth in eight cases, the
tongue in eight cases, and the hard palate in one case.
Three of the eight patients with tongue cancer suffered
from regional advanced disease, in contrast to only one
of the eight patients with the floor of mouth as primary
site.
Adjuvant radiotherapy was performed in 59% of the
patients in the PNI group and in 45% of the patients in
the control group. Of the seven patients in the PNI
Fig. 3. Study setup. PNI5perineural invasion.
TABLE I.
Overall Demographic and Clinical Data
No. Gender Age Location T N
Tumor
Stage
Type
A
Type A
Epineurium
Type A
Perineurium
Type A
Endoneurium
Type
B
Recurrence-Free
Survival (months)
Recurrence
Site
Overall
Survival
(months)
1 M 54 tongue 1 0 I 1 1 1 0 1 47 regional 47
2 F 44 tongue 2 0 II 1 1 0 0 1 25 regional 40
3 M 39 tongue 2 0 II 1 1 1 0 0 no recurrence – alive
4 F 61 hard
palate
2 0 II 1 1 1 0 1 4 local 16
5 F 49 floor of
mouth
2 0 II 1 0 1 0 1 no recurrence – alive
6 M 60 tongue 2 1 III 1 1 0 0 1 no recurrence – alive
7 F 62 tongue 1 1 III 1 1 0 0 1 no recurrence – alive
8 M 46 floor of
mouth
2 1 III 0 0 0 0 1 3 local 22
9 M 49 floor of
mouth
2 1 III 0 0 0 0 1 7 local 28
10 M 72 tongue 2 1 III 1 1 0 0 1 8 regional 13
11 F 65 tongue 2 1 III 1 0 1 1 0 8 regional 9
12 M 48 floor of
mouth
2 2b IV 1 1 0 0 0 no recurrence – alive
13 F 62 floor of
mouth
4a 1 IV 1 1 1 0 0 0 local 5
14 M 60 tongue 2 2b IV 0 0 0 0 1 3 local and
regional
18
15 M 59 floor of
mouth
4 2c IV 1 1 1 1 0 2 local 5
16 F 60 floor of
mouth
4a 2c IV 1 1 0 0 1 no recurrence – alive
17 M 69 floor of
mouth
4a 0 IV 1 1 0 0 1 no recurrence – alive
f5 female; m5male; T and N according TNM.
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group who did not receive adjuvant radiotherapy, rea-
sons include patient’s primary decision (n52); early ter-
mination of already started radiotherapy on patient’s
demand (n5 2); and a sentinel lymph node result,
pN0(i1) and pN1(mi), for which a neck dissection was
chosen over radiotherapy (n5 3). Postoperative radiation
therapy prescription dose was 60 Gy to 66 Gy applied in
30 to 33 fractions, five times a week, administered to the
tumor bed area, whereas elective treatment of the nodal
pathways of 54 Gy (low risk) or 60 Gy (higher risk) was
given. All treatments were performed using simultane-
ously integrated boost technique. In patients with resid-
ual gross tumor, 70 Gy were applied. Concomitant
chemotherapy consisted of cisplatin in all cases, except
for two cases in the PNI group for which cetuximab was
used. As shown in Table II, concomitant chemotherapy
was expectedly not added equally in both groups.
Histologically, the reevaluation of the histological
slides revealed five patients (29%) with exclusively Lie-
big type A pattern, three patients (18%) with exclusively
Liebig type B pattern, and nine patients (53%) with a
mixed Liebig type A and B pattern. That is, of the 17
patients with PNI, 14 (82%) displayed a type A pattern
and 12 (71%) a type B pattern. The corresponding data
is shown in Figure 3 and Table I.
The results from the survival analysis are shown in
Figure 4 (a–f). The 5-year overall survival of the PNI
group (n5 17) was 41.2%, compared to 72.5% in the con-
trol group (n5 51, P< 0.05, log-rank test). The 5-year
recurrence-free survival for the same groups was 47.1%
and 80.4%, respectively (P< 0.05). The analysis of the
histologic subcategories showed a different 5-year recur-
rence-free survival rate for the PNI patients with a type
A pattern (n5 14) of 57.1% versus 81.0% in their
matched controls, with no PNI (n542) as a trend
(P5 0.05). Patients whose histology showed the pres-
ence of type B pattern (n512) had a 5-year recurrence-
free survival of 50.0% versus 80.6% in their matched
controls (n536, P< 0.05). The nine patients who had a
mixed type A and B pattern are a part of both men-
tioned PNI subgroups. Survival analysis of subcatego-
ries within the PNI group, for example, patients with
TABLE II.
Demographic and Clinical Data of Subgroups
Stage I–IV PNI Group Control Group P Value
n 5 17 51
Gender (m:f) 10:7 30:21 1.00
Age (mean) 566 9 years 566 9 years 1.00
Location tongue 8 tongue 32 0.27
floor of mouth 8 floor of mouth 18 0.40
hard palate 1 buccal mucosa 1 –
Adjuvant radiotherapy 10 (59%) 23 (45%) 0.41
Concomittant chemotherapy 10 (59%) 9 (18%) 0.004
Stage I and II PNI Group Control Group P Value
n 5 5 17
Stage (I:II) 1:4 3:14 1.00
Gender (m:f) 2:3 6:11 1.00
Age (mean) 496 8 y 506 10 y 0.89
Location tongue 3 tongue 13 0.59
floor of mouth 1 floor of mouth 4 1.00
hard palate 1 –
Adjuvant radiotherapy 2 (40%) 1 (6%) 0.12
Concomittant chemotherapy 0 (0%) 0 (0%) 1.00
Stage III and IV PNI Group Control Group P Value
n 5 12 34
Stage (III:IV) 6:6 9:25 0.16
Gender (m:f) 8:4 24:10 1.00
Age (mean) 596 8 y 586 8 y 0.68
Location tongue 5 tongue 19 0.51
floor of mouth 7 floor of mouth 14 0.34
buccal mucosa 1 –
Adjuvant radiotherapy 8 (67%) 22 (65%) 1.00
Concomittant chemotherapy 8 (67%) 9 (26%) 0.02
f5 female; m5male.
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exclusively type A (n5 5) versus patients with exclu-
sively type B (n5 3) showed no significant difference
(data not shown).
Patients with PNI and local disease (TNM stage I
and II) (n55) had a 5-year recurrence-free survival of
60% versus 94.1% in the matched control group (n517,
P< 0.05). The 5-year recurrence-free survival rate of
patients with PNI and regional advanced disease (TNM
stage III and IV) (n512) was 41.7% versus 73.5 in their
matched control group (n5 34, P< 0.05).
Fig. 4. Kaplan-Meier curves of the OS and RFS of the total group in (a) and (b), of RFS of the histologic subtypes Liebig type A and Liebig
type B in (c) and (d), and of the RFS of early disease and late disease in (e) and (f). OS5overall survival; PNI5perineural invasion;
RFS5 recurrence-free survival.
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DISCUSSION
The clinical, histological, and biological features of
PNI have been studied extensively in different kinds of
cancer. It is well known that PNI in oral carcinoma is
associated with higher recurrence rates and a lower
disease-free survival.11,12 Remarkably, not only the risk
of local recurrence, but also the risk of regional recur-
rence is increased, which indicates that PNI is not only
a question of tumor-free margins and a local further-
than-expected spread along the nerves.13 This feature
could be observed in our cohort as well as with five cases
of local recurrence, four cases of regional recurrence,
and one case with local and regional recurrence.
Although described in studies as early as 1963,1 a stand-
ardized definition of PNI among pathologists has not
been established in total accordance.9,14 The definition of
Liebig et al.9 allows different patterns of histologic find-
ings to conclude with the diagnosis of PNI. In our study,
most patients with PNI showed both infiltration and
encircling of the nerve (53%). Infiltration without encir-
cling of the nerve only was observed in three cases
(18%). The histology of five patients (29%) showed exclu-
sively encircling of the nerves without infiltration. The
histologic reevaluation was performed with a focus on
identifying these histologic patterns. Because most cases
showed a mixed pattern, it seems possible that once one
pattern is present, it is just a question of time and
tumor growth until the other pattern develops as well.
This supports the Liebig classification in summarizing
both patterns independently as PNI, also because there
was no difference in the recurrence-free survival of the
histologic subgroups. This is in accordance with results
of Gil et al., who examined paranasal sinus tumors.15
However, comparison was limited due to small sample
sizes.
The overall survival rates, the recurrence-free
rates, and the demographic data of our total PNI and
control group are in accordance with reported data in lit-
erature.16 The demographic data of the stage I and II
subgroup showed more affected women, a younger mean
age, and predominantly the tongue as the primary
tumor site when compared to the stages III and IV sub-
group. For example, this could indicate that older men
with the floor of the mouth as the primary site are more
likely to notice their disease with delay, or that this
tumor site predisposes a more rapid tumor progress into
a higher tumor stage.
It is known that PNI has an impact on early stage
oral SCC.17 In our study, stage I and II patients without
PNI had an excellent recurrence-free survival rate of
94.1%. This rate dropped to 60% if PNI was present,
which is lower than the recurrence-free survival rate of
stage III and IV patients without PNI. And even in
extended disease, PNI had a significant additional
impact on recurrence-free survival.
CONCLUSION
In the majority of PNI cases, both histologic pat-
terns (encircling and infiltration of the nerve) were pres-
ent. The different histologic patterns qualifying for PNI,
according to Liebig et al., showed no different clinical
outcome.9 The presence of PNI in early disease (stage I
and II) has a particularly serious impact on outcome in
oral SCC and warrants a more aggressive primary
treatment.
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